Journals / Ege Tıp Dergisi / 2014 / Cilt: 53 - Sayı: 1

Relationship of mean platelet volume to an acute ischemic stroke

Akut iskemik inme ile ortalama trombosit hacmi ilişkisi

Pages
1–6
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In acute stroke patients, the MPV value was significantly higher compared to the acute stroke patients within the control group, so that a high MPV value may be one of the factors that play a role in the development of schemic strokes and cerebrovascular disease, suggesting a rise in a secondary phenomenon.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Platelet activation has a major role to play in the development of ischemic cerebrovascular disease.
📊
Key Findings & Data:Materials and Methods: This study compared MPV values in 110 patients who were hospitalized with the diagnosis of the first and recurrent stroke with the risk factors and stroke subtypes, and 58 control patients who were age and sex matched to patients.
💡
Conclusion & Impact:Conclusion: In acute stroke patients, the MPV value was significantly higher compared to the acute stroke patients within the control group, so that a high MPV value may be one of the factors that play a role in the development of schemic strokes and cerebrovascular disease, suggesting a rise in a secondary phenomenon.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Platelet activation has a major role to play in the development of ischemic cerebrovascular disease. Mean platelet volume (MPV) is reported to be a good indicator of platelet activity. In this study, we aimed to determine the position of MPV in the pathogenesis of ischemic strokes. Materials and Methods: This study compared MPV values in 110 patients who were hospitalized with the diagnosis of the first and recurrent stroke with the risk factors and stroke subtypes, and 58 control patients who were age and sex matched to patients. MPV parameters are measured in the acute period of the stroke and 24 hours later. We nvestigated the relationship between the mean platelet volume and risk factors, stroke subtypes, haematological and biochemical parameters, white blood cell, platelet, cholesterol, triglycerides, LDL cholesterol, glucose, erythrocyte sedimentation ratio (ESR), partial thromboplastin time (aPTT), and C-reactive protein (CRP). Results: The MPV parameter was found to be higher in the case group than the control group (p <0.001). In the case group, we found a weak significant negative correlation between platelet count (r = -0.20 p <0.05) and MPV parameter measured upon admission in the case group. Conclusion: In acute stroke patients, the MPV value was significantly higher compared to the acute stroke patients within the control group, so that a high MPV value may be one of the factors that play a role in the development of schemic strokes and cerebrovascular disease, suggesting a rise in a secondary phenomenon.

Özet

Amaç: Trombosit aktivasyonu iskemik serebrovasküler hastalığın gelişmesinde majör role sahiptir. Ortalama trombosit hacminin (OTH) trombosit aktivitesinin iyi bir göstergesi olduğu bildirilmektedir. Bu çalışmada OTH’nin iskemik inme patogenezindeki yerinin belirlenmesi amaçlandı. Gereç ve Yöntem: Çalışmada risk faktörleri ve inme alt tiplerine göre değerlendirilen, ilk ve rekürren inme tanısı ile yatırılarak tetkik ve tedavi edilen 110 olgu yaş ve cinsiyet eşleştirilmiş 58 kontrol hastası OTH açısından karşılaştırıldı. Hastaların OTH değerlerine inmenin akut döneminde, ilk 24 saatte bakıldı. Ortalama trombosit hacminin inme geçiren hastalarda risk faktörleri, inme alt tipleri, hematolojik ve biyokimyasal parametreler (lökosit, trombosit, kolesterol, trigliserid, LDL kolesterol, glukoz, eritrosit sedimentasyon hızı (ESR), parsiyel tromboplastin zamanı (aPTT), C-reaktif protein (CRP) ile ilişkisi araştırıldı. Bulgular: Olgu grubunun OTH değerleri kontrol grubuna göre anlamlı yüksek bulundu. (p<0.001). Olgu grubunda başvuru sırasındaki OTH değeri ile trombosit sayısı arasında zayıf derecede anlamlı negatif korelasyon bulundu (r=-0.20 p<0.05). Sonuç: İnme hastalarında akut dönemde OTH’nin kontrol grubuna kıyasla anlamlı yüksek bulunması OTH anormalliğinin iskemik inme gelişiminde rol oynayan etmenlerden biri olabileceğini, serebrovasküler hastalık sonucunda ortaya çıkan sekonder bir fenomen olmadığını düşündürmektedir.

🔖

Cite This Article

DEVECİ, Ş., ÇELEBİ, A., GÜRSOY, A., KOLUKISA, M., AŞKIN, S., HAKYEMEZ, A. (2014). Relationship of mean platelet volume to an acute ischemic stroke. Ege Tıp Dergisi, Cilt: 53 - Sayı: 1, 1–6. https://ajindex.com/articles/205775

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet 2003; 362(9391):1211-24
  2. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: A review of population-based studies of incidenceprevelence and case fatality in the 20th century. Lancet Neurol 2003; 2(1): 43-53
  3. Özdemir G, Özkan S, Uzuner N, Özdemir Ö, Gücüyener D. Türkiye’de beyin damar hastalıkları için majör risk faktörleri. TürÇok Merkezli Strok Çalışması. Türk Beyin Damar Hastalıkları Dergisi 2000; 6(2): 31-5
  4. Utku U, Çelik Y. İnmede etiyoloji, sınıflandırma ve risk faktörleri. In: Balkan S (ed). Serebrovasküler Hastalıklar, 2.BaskAntalya: Öncü Basımevi; 2005: 61-7
  5. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340(2):115-26
  6. Jakubowski JA, Thomson CB, Vaillaincourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing sizeBr J Haematol 1983;53(3):503-11
  7. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding timeplatelet tromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983: 32(5):443-60
  8. Haver VM, Gear AR. Functional fractionation of platelets. J Lab Clin Med 1981;97(2):187-204
  9. Hekimsoy Z, Payzin B, Ornek T, Kandoğan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complication2004;18(3):173-6
  10. Senaran H, İleri M, Altınbaş A, Kosar A, Yetkin E, Ozturk M, Karaaslan Y, Kirazlı S. Thrombopoietin and mean platelet volumin coronary artery disease. Clin Cardiol 2001;24(5):405-8
  11. O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in stroke patients. Stroke 1995;26(6):995-9
  12. Bath P, Algert C, Chapman N, Neal B (PROGRESS Collaborative Group). Assosiation of mean platelet volume with risk ostroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35(3):622-6
  13. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysi1996;7(2):157-61
  14. Sharp DS, Benowitz NL, Bath PM, Martin JF, Beswick AD, Elwood PC. Cigarette smoking sensitizes and desensitizeimpedance-measured ADP-induced platelet aggregation in whole blood. Thromb Haemost 1995;74(2):730-5
  15. Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA. Large platelets circulate in an activatestate in diabetes mellitus. Semin Thromb Hemost 1991;17(4):433-8
  16. Zuberi BF, Akhtar N, Afsar S. Comparison of mean platelet